Compare TALO & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TALO | LMAT |
|---|---|---|
| Founded | 2011 | 1983 |
| Country | United States | United States |
| Employees | 700 | N/A |
| Industry | Oil & Gas Production | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.6B |
| IPO Year | 2017 | 2006 |
| Metric | TALO | LMAT |
|---|---|---|
| Price | $16.58 | $101.01 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 5 |
| Target Price | $18.00 | ★ $105.80 |
| AVG Volume (30 Days) | ★ 1.5M | 210.9K |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 0.93% |
| EPS Growth | N/A | ★ 30.57 |
| EPS | N/A | ★ 0.68 |
| Revenue | ★ $1,780,070,000.00 | $249,602,000.00 |
| Revenue This Year | $4.18 | $14.21 |
| Revenue Next Year | N/A | $8.88 |
| P/E Ratio | ★ N/A | $148.23 |
| Revenue Growth | N/A | ★ 13.53 |
| 52 Week Low | $7.67 | $78.35 |
| 52 Week High | $17.01 | $118.01 |
| Indicator | TALO | LMAT |
|---|---|---|
| Relative Strength Index (RSI) | 62.75 | 39.65 |
| Support Level | $10.49 | $82.65 |
| Resistance Level | $17.01 | $114.98 |
| Average True Range (ATR) | 0.55 | 5.12 |
| MACD | 0.09 | -1.08 |
| Stochastic Oscillator | 98.45 | 26.42 |
Talos Energy Inc is an independent oil and gas company predominantly involved in offshore exploration and production. The company has operations in the United States, the Gulf of Mexico, and offshore Mexico. The company's operating segments are; exploration and production of oil, natural gas and NGLs, and the CCS segment. Its revenue is generated from the sale of oil, natural gas, and NGL quantities sold to purchasers.
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.